Ergoteles LLC Johnson & Johnson Transaction History

Ergoteles LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $875,473 - $942,175	5,672 New	5,672 $938,000
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $12.7 Million - $14.1 Million	78,671 New	78,671 $12.9 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $194,444 - $215,743	-1,247 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $21.5 Million - $23.9 Million	-133,203 Reduced 99.07%	1,247 $201,000
Q2 2021 Aug 12, 2021	BUY	$159.48 - $171.07 $21.4 Million - $23 Million	134,450 New	134,450 $22.1 Million
Q1 2021 May 12, 2021	SELL	$153.07 - $170.48 $26.5 Million - $29.5 Million	-172,871 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $17 Million - $19.5 Million	123,871 Added 252.8%	172,871 $27.2 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $6.88 Million - $7.54 Million	49,000 New	49,000 $7.3 Million

4,239

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.